| Why carry out this study? |
| Hypertriglyceridemia is an important risk factor for atherosclerotic cardiovascular disease (ASCVD) events, even in statin-treated patients. |
| This study attempted to estimate the prevalence of hypertriglyceridemia in statin-treated patients in the United States, including those with type 2 diabetes or ASCVD. |
| What was learned from this study? |
| The overall prevalence of statin-treated patients with triglyceride levels ≥ 150 mg/dl in the United States is 25.9%. |
| A total of 12.3 million statin-treated patients have triglyceride levels ≥ 150 mg/dl, including as many as 6.4 million with type 2 diabetes or ASCVD. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.